Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, July 17, 2026 (GLOBE NEWSWIRE) -- The "Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2026" has been added to ResearchAndMarkets.com's offering.The Co-promotion and...
-
The first patient has been dosed in the intermittent weekly dosing (QW) arm of the ongoing Phase 1 clinical trial of AN9025, a pan-RAS(ON) inhibitor.
-
NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition
-
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
-
National Tsing Hua University and Top Taiwan Venture Capital Co., Ltd. officially launched their collaboration and establishment of the NTHU Future Fund.
-
Investigational WJ-MSC therapy associated with no deaths at 12 months and statistically significant improvements in long-term cognitive and motor outcomes Results support planned expansion of the...
-
AI-enabled facial, fingerprint, iris, and multimodal biometrics are transforming medical devices, remote monitoring, and digital healthcare.
-
호주 아들레이드, July 10, 2026 (GLOBE NEWSWIRE) -- 호주에 본사를 둔 글로벌 임상시험수탁기관(CRO)인 아반스 클리니컬(Avance Clinical)은 7월 15일부터 19일까지 대만 타이베이 난강전시센터(Taipei Nangang Exhibition Center, TaiNEX)에서 열리는 'BIO Asia–Taiwan...
-
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026
-
Avance Clinical to Showcase Asia and China Growth Strategy at BIO Asia–Taiwan 2026